US Pharma MarketingJohnson & Johnson launches ‘Generation Fine’ depression project
Johnson & Johnson launches ‘Generation Fine’ depression project is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
You’ve heard of Gen Z, but now Johnson & Johnson wants you to be aware of “Generation Fine” as it looks to boost understanding around depression treatment.
Source: FiercePharma